Transient cerebral dysfunction secondary to high-dose methotrexate Journal Article
| Authors: | Walker, R. W.; Allen, J. C.; Rosen, G.; Caparros, B. |
| Article Title: | Transient cerebral dysfunction secondary to high-dose methotrexate |
| Abstract: | A transient acute neurologic syndrome occurred in 22 patients receiving high-dose methotrexate (HDMTX) (8 to 9 g/m2) for a variety of malignancies. The neurologic signs were similar in all cases. The syndrome occurred an average of six days after the second or third weekly treatment. Common findings included behavioral abnormalities, focal sensorimotor signs, and abnormal reflexes. Signs often alternated from one side to the other. Evaluations including computed tomography (CT) scan, lumbar puncture, hemogram, and blood chemistry were normal. The EEG revealed some slowing in all cases. The cause of this syndrome is unknown. It is transient and usually does not recur. Its appearance does not preclude further treatment with HDMTX. |
| Keywords: | cancer chemotherapy; clinical article; paresthesia; methotrexate; neurotoxicity; cyclophosphamide; vincristine; central nervous system; psychological aspect; folinic acid; brain disease; dactinomycin; bleomycin; behavior; reflex; drug therapy; aphasia; hemiparesis; adverse drug reaction; electroencephalogram; therapy; intravenous drug administration; nervous system; intoxication; convulsion; human; priority journal; brain dysfunction; monoparesis |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 4 |
| Issue: | 12 |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 1986-12-01 |
| Start Page: | 1845 |
| End Page: | 1850 |
| Language: | English |
| DOI: | 10.1200/jco.1986.4.12.1845 |
| PUBMED: | 3465876 |
| PROVIDER: | scopus |
| DOI/URL: | |
| Notes: | Article -- Export Date: 18 August 2021 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work